These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Agonists of beta2 adrenergic receptor in the therapy of obstructive diseases]. Płusa T Pol Merkur Lekarski; 2010 Jan; 28(163):8-12. PubMed ID: 20369715 [TBL] [Abstract][Full Text] [Related]
5. FDA alerts asthmatics to drug safety risk. Ellis C Nat Rev Drug Discov; 2003 Oct; 2(10):765. PubMed ID: 14577428 [No Abstract] [Full Text] [Related]
6. Risk of non-fatal cardiac failure and ischaemic heart disease with long acting beta 2 agonists. Martin RM; Dunn NR; Freemantle SN; Mann RD Thorax; 1998 Jul; 53(7):558-62. PubMed ID: 9797754 [TBL] [Abstract][Full Text] [Related]
7. The FDA-mandated trial of safety of long-acting beta-agonists in asthma: finality or futility? Sears MR Thorax; 2013 Feb; 68(2):195-8. PubMed ID: 22858928 [No Abstract] [Full Text] [Related]
11. Induction and reduction of muscle tremor upon acute and repeated administration of the beta 2-agonists terbutaline, salbutamol and tulobuterol. Schaffler K; Reeh PW Int J Clin Pharmacol Ther Toxicol; 1987 Dec; 25(12):673-82. PubMed ID: 2893778 [TBL] [Abstract][Full Text] [Related]
13. Excess mortality in patients with asthma on long-acting beta2-agonists. Hasford J; Virchow JC Eur Respir J; 2006 Nov; 28(5):900-2. PubMed ID: 17074917 [No Abstract] [Full Text] [Related]
14. [Comments of the German Airway League and the German Respiratory Society to the US Food and Drug Administration (FDA)'s announcement from February 18th 2010 on the use of long acting beta-2 agonists in treatment of asthma]. Kardos P; Berdel D; Buhl R; Criée CP; Freihorst J; Gillissen A; Karg O; Pfeifer M; Magnussen H; Rabe KF; Teschler H; Vogelmeier C; Welte T; Wettengel R; Worth H Pneumologie; 2010 Jun; 64(6):333-5. PubMed ID: 20533125 [No Abstract] [Full Text] [Related]
15. Evidence based answers--is salmeterol safe in asthma? Spurling G; Doust J Aust Fam Physician; 2006 Aug; 35(8):625-6. PubMed ID: 16894440 [No Abstract] [Full Text] [Related]
16. Severe unwanted effects associated with betasympathomimetics when used in the treatment of premature labour: causes, incidence and preventative measures. Martin AJ Br J Clin Pract; 1981 Sep; 35(9):325-9. PubMed ID: 6120000 [No Abstract] [Full Text] [Related]
17. Double-blind comparison of tulobuterol and salbutamol in chronic obstructive pulmonary disease. Germouty J Clin Ther; 1986; 8(5):546-53. PubMed ID: 2876775 [TBL] [Abstract][Full Text] [Related]
18. Comparison of oral bambuterol and inhaled salmeterol in patients with symptomatic asthma and using inhaled corticosteroids. Crompton GK; Ayres JG; Basran G; Schiraldi G; Brusasco V; Eivindson A; Jamieson AH; Olsson H Am J Respir Crit Care Med; 1999 Mar; 159(3):824-8. PubMed ID: 10051257 [TBL] [Abstract][Full Text] [Related]